Eris Lifesciences Ltd Sustainability Reports

Eris Lifesciences Limited manufactures and markets branded pharmaceutical formulations primarily within India. The company focuses on chronic and acute therapeutic lifestyle segments including diabetes care, cardiology, nutrition, neuroscience, and dermatology.

Sector: Manufacturing

Country: India

Exchange: National Stock Exchange of India

LEI: 33580023SPXBP9PCKQ56

FIGI: BBG0022GB406

9 reports from 2017 to 2025

• Eris Lifesciences Ltd 2025 Annual Report
• Eris Lifesciences Ltd 2024 Annual Report
• Eris Lifesciences Ltd 2023 Annual Report
• Eris Lifesciences Ltd 2022 Annual Report
• Eris Lifesciences Ltd 2021 Annual Report